Jun is able to suppress p53 gene transcription, and Jun À/À mouse embryonic fibroblasts (MEFs) have increased expression of p53, 20 a severe proliferation defect, undergo premature senescence, and are sensitive to p53-induced growth arrest on UV irradiation. 4, [20] [21] [22] JunD also interacts with the p53 pathway as Jund À/À MEFs exhibit a proliferation defect, which is less severe than that of Jun À/À cells and is caused likely by increased p19ARF expression. 23 Jun also stimulated cell-cycle progression through induction of cyclin D1 transcription 24 and expression of cyclin D1 is downregulated in Jun À/À MEFs. 20, 21 Immortalized Jund À/À cells show increased proliferation likely as a consequence of increased cyclin D1 expression. 23 Overexpression of JunD in immortalized 3T3 cells and T cells resulted in reduced proliferation suggesting that JunD is a negative regulator of proliferation. 25, 26 The nuclear erythroid-related transcription factors (Nrf) are important regulators of cellular redox homeostasis through their capacity to induce the expression of reactive oxygen species detoxification enzymes and other antioxidant proteins. Similar to Jun-deficient embryos, Nrf1 null embryos die around E13.5 of embryonic development and display small livers, probably because of the failure in antioxidant gene expression and increased apoptosis. 27 Moreover, embryonic stem (ES) cells deficient in Nrf1 do not contribute to adult livers in chimeras. 27 In contrast, Nrf2 -similar to JunD -is dispensable for mouse development, 28 and Nrf2 is involved in G2/M cell-cycle block and controls Akt activity. 29 Adult livers lacking Nrf2 display reduced Jun levels 30 and exhibit impaired liver regeneration and oxidative stress. 31 Furthermore, Nrf2 has a function in age-related diseases, such as neurodegeneration, chronic inflammation, and cancer. 32 Interestingly, fibroblast proliferation was not affected neither by the loss of Nrf1 nor Nrf2, 27 although double mutant Nrf1-Nrf2 MEFs enter early senescence, possibly because of increased p53 levels and severe oxidative stress. 27 Here, we show that JunD can substitute for Jun during fetal development, although embryos display cardiac defects similar to fetuses lacking Jun. Increased H 2 O 2 production and downregulation of Nrf1 and Nrf2 expression of Jundeficient fetal livers was also rescued by JunD. It seems that Jun and JunD can protect cells and tissues by regulating detoxification and antioxidant genes as was reported for Nrf1/Nrf2. MEFs was abolished by high levels of EGF or HB-EGF, but these treatments had no effect on cells lacking Jun. Thus, in contrast to JunB, JunD cannot functionally replace Jun in fibroblast proliferation, but has the potential to rescue mouse development to birth.
Results

Generation of JunD knock-in mice. A Jun
JunD (Jun d/ þ ) knock-in allele was generated to disrupt expression of the endogenous Jun gene allowing simultaneous expression of the complete coding region of JunD. Correctly targeted ES cell clones were identified by PCR and verified by Southern blot analysis (Figure 1a and b) . Heterozygous offspring were crossed to a general deleter-Cre to remove the floxed PGKbgeo selection cassette (Figure 1a To test whether the described targeting event replaced Jun with the JunD coding region, Jun d/ þ mice were crossed with Jund À/À mice. Analysis of 3-week-old Jun d/ þ Jund À/À mouse tissues and various organs, prepared from E12.5 embryos, showed Jund expression in which Jun is normally expressed (Figure 1d and data not shown). There was no change in Junb expression. Thus, the JunD knock-in allele is expressed with a pattern similar to the endogenous Jun gene. Table 1A ). The remaining 65% died between E12.5 and E13.5 because of defects in the neural tube region and/or a complete delay of development ( Figure 2b ; Table 1A and data not shown). Figure 3k ). In both mouse and human, an AP-1 responsive TRE element (TGT C TCA) has been described in the cyclin D1-promoter proximal region. 33 ChIP experiments showed that Jun and JunD bound to the TRE element indicating that Jun and JunD directly control the transcription of cyclin D1 through the TRE-promoter site (Figure 3m ).
Reduced epidermal growth factor receptor expression in
MEFs. Next, we analyzed the function of epidermal growth factor receptor (EGFR), a Jun-target gene having a major function in fibroblast and keratinocyte proliferation. 34 Expression of EGFR mRNA was downregulated, whereas expression of the ligand HB-EGF or TGF-a was unchanged in Jun MEFs, but had little effect on Jun À/À MEFs ( Figure 4d ). In contrast, pharmacological inhibition of the EGFR pathway induced cell death independent of the genotype. Inhibition of EGFR (20-0.02 mm), ErbB2 (20 mm), and EGFR-ErbB2-ErbB4 (20, 2 mm) had either no effect on proliferation or Increased oxidative stress in Jun À/À MEFs and fetal livers is rescued by JunD. JunD was identified to have an important function in regulating oxidative stress by controlling H 2 O 2 levels. 13 We next analyzed oxidant toxicity in Jun (Figure 5c ) compared with wild-type MEFs. As reported, 35 low levels of Glutamate-cysteine ligase, catalytic subunit (Gclc) and glutathione (GSH) synthase (Gss), important enzymes responsible for maintaining GSH homeostasis, were found to be expressed at similar levels in Jun d/d and Jun À/À MEFs, although the difference was not significant (Figure 5c ). Glutamate-cysteine ligase, modifier subunit (Gclm) and the JunD-target genes Nox4, Cdo1, and Mgst1 were found to be expressed at similar levels in Jun (Figure 5d and data not shown). Next, we asked whether the defect in H 2 O 2 production and Nrf1/2 expression is cell-type dependent. Secretion of H 2 O 2 in Jun d/d fetal liver cells was found to be similar to wild-type levels ( Figure 6a) . However, increased H 2 O 2 secretion was observed in Jun-deficient fetal liver cells (Figure 6a ). Juntarget genes, such as p53 and p21, were undetectable at the protein level in any of the fetal liver extracts analyzed (Figure 6b ). Interestingly, expression of Nrf1, Nrf2, Gclc, and Gss was downregulated in Jun À/À fetal liver cells, but rescued by JunD (Figure 6c ). There was no difference in expression of the JunD-target genes Nox4, Cdo1, and Mgst1 (Figure 6c) . Thus, JunD can rescue the oxidative stress response in fetal liver cells lacking Jun, but not in MEFs, suggesting that this phenotype is cell-type specific.
Discussion
In this study, we show that JunD can partially substitute for Jun-specific functions in embryonic development, such as fetal liver development to birth. Jun-deficient fetal livers secreted high levels of H 2 (Figure 6d) .
When JunD was expressed from the Jun locus, some fetuses developed to birth, showed normal liver architecture, but displayed severe cardiac defects, as earlier described for a JunB knock-in gene substitution of Jun. 16 Besides these similarities, several differences were observed. First, all Jun
newborns died immediately after birth, whereas JunB knockin mice survived until postnatal day 4. In addition, 50% of Jun d/d embryos died around E12.5 displaying defects in neurulation and growth retardation. However, JunD -similar to JunB -can fully compensate for the lack of Jun in fetal liver development, as impaired proliferation and increased apoptosis of Jun-deficient fetal livers was fully rescued in vivo. Conversely, a functional Jun gene is essential for proper heart development, as neither JunB nor JunD, when expressed from the Jun locus, rescued the heart malformation. In contrast, Jun-deficient mice ectopically expressing a JunB transgene are born without liver and heart defects. 16 In addition, a JunB transgene is also sufficient to bypass embryonic lethality observed in Junb À/À embryos. 16, 17 JunD does not have the ability to rescue both Jun-dependent liver and heart defects in a gene-dosage-dependent manner. Jund transgenic mice 26 in a Jun À/À background did not develop beyond E15.5, possibly because of different JunD functions in activating/repressing specific target genes (data not shown). This implies that the physiological functions of the structurally similar proteins JunB and JunD partially overlap. EGFR-dependent signal is necessary for effective activation. A regulatory loop from EGFR signaling to Jun-dependent EGFR expression has been described. 34 A decrease in EGFR expression and EGFR signaling was observed in Jun d/d MEFs and cells lacking Jun. EGFR and Jun have also a prominent function in regulating embryonic eyelid closure. JunD and JunB knock-in mice are born with open eyes, similar to defects observed in mice lacking Jun specifically in the epidermis or disruption of the EGFR. 34, 36 This failure was associated with reduced EGFR expression, supporting an EGFR-dependent signaling pathway to regulate gene expression through AP-1.
Jun d/d cells responded to EGF or HB-EGF stimulation. In contrast, MEFs lacking Jun did not respond to growth factor treatment, and EGFR and Akt phosphorylation were still impaired. In developing Drosophila eye, low EGFR activity maintains quiescence, similar senescence in which EGF responsiveness and binding is lost and EGFR expression decreases with age. 37 In addition, reduced EGFR phosphorylation has been observed in senescent cells compared with proliferating cells. 38 However, the single defect in EGFR expression might not be the main cause of senescence, as MEFs lacking EGFR do not show an obvious proliferation defect (unpublished data). Expression of other EGFR family members was neither affected in Jun À/À fibroblasts nor did pharmacological inhibition of the EGFR pathway interfere with proliferation. EGF treatment did activate p38 activity, which was slightly prolonged in Jun À/À MEFs. Activation of p38 can also result in premature senescence of MEFs. 39 Importantly, inhibition of the p38 pathway in Mkk7 À/À cells rescued these cells from premature senescence. 40 Thus, a combined effect of defective EGFR signaling, prolonged p38 expression, increased p53 and p21, and reduced CDC2 protein levels may be responsible for the response of Jun À/À cells to certain growth factors. JunD apparently rescues the endogenous Jun promoter on high EGF treatment through restoration of Jun/AP-1-dependent factors.
Deficiencies in H 2 O 2 metabolism were observed in Jundeficient fetal livers and MEFs. JunD rescued H 2 O 2 defects in fetal livers, but not in MEFs. Jun and Nrf1 mutant mice display similar phenotypes, such as embryonic lethality and impaired liver degeneration, 27 suggesting that these transcription factors may have overlapping but non-redundant functions. On the other hand, JunD and Nrf2 mutant mice are viable, and these transcription factors seem to regulate oxidative stress tolerance and longevity. 14, 41 Thus, Jun and JunD have the ability to protect multiple tissues by regulating detoxification and antioxidant genes as well as cell type-specific targets. However, Nrf1 may be more critical for detoxification, as Nrf2 and expression of other detoxification enzymes is strongly dependent on the genetic background (data not shown).
In summary, JunB and JunD can substitute for Jun in embryonic development. However, Jun functions in fibroblast On the other hand, JunD is a weaker transactivator, exhibits lower DNA binding, and is atypically expressed. 42 JunD is likely to bind to different partners than Jun, and differences in dimer composition might, therefore, explain why JunB can rescue proliferation, but not JunD. Moreover, JunD is a JNK substrate, 43 whereas JunB is not, although impaired N-terminal phosphorylation might not be the reason for incomplete rescue, as Jun AA mice are viable and develop normally. 15 JunD does differ also from Jun and JunB, as it is not subjected for ubiquitin-mediated degradation. 42 Thus, prolonged binding and stability of JunD might affect activation or repression of specific target genes. Therefore, Jun, JunB, and JunD are not functionally equivalent and as shown have both overlapping and independent functions. This study identified a novel mechanism how Jun proteins and EGFR signaling control cellular proliferation, cell-cycle arrest/senescence and the response to stress.
Materials and Methods
Gene targeting and generation of knock-in mice. The JunD genomic DNA was amplified by PCR, sequence verified, and was cloned into the Jun-mini locus vector.
15 R1 ES cells were electroporated with 10 mg of the Not-I-linearized knock-in construct and cells were screened for homologous recombination. Four correctly targeted clones out of 1000 analyzed were identified by PCR and Southern analyses as described earlier. 15, 16 Mouse chimeras were generated by injecting correctly targeted ES cell clones into C57/BL6 blastocysts, and germline transmission was obtained from two independent clones (2H4, 11C11). Heterozygous knock-in mice (Jun d/ þ ) were maintained in a mixed 129 (sv) Â C57/BL6 genetic background. Heterozygous mice were then bred to a general Cre-Deleter. Jund À/À mice used in this study have been described earlier. 9 Histology. Fetuses and tissues were fixed in 4% formaldehyde in PBS, embedded in paraffin, 5 mm sectioned, and stained either with hematoxylin and eosin according to standard procedures or processed further. Immunohistochemical staining for Ki67 (Novocastra, New Castle, UK) was performed using the ABC staining kit (Vector Laboratories, Burlingame, CA, USA) according to the manufacturer's recommendations. Apoptosis was measured by TUNEL (terminal deoxyribonucleotide transferase-mediated dUTP nick end-labeling staining) using an in situ Cell Death Detection kit (Roche, Indianapolis, IN, USA).
Isolation, growth, and transfection of primary MEFs. MEFs were prepared from wild-type, Jun À/À and Jun d/d E12.5 fetuses. A total of 2-4 independent MEF lines per genotype were used for the studies. MEFs were cultured in Dulbecco's modified Eagles medium (DMEM) containing 10% FCS, 2 mM L-glutamine and 100 U/ml penicillin/streptomycin. Cells at 70% confluence were arrested by serum deprivation for 48 h in medium containing 0.5% serum and stimulated to re-enter cell cycle by adding medium containing 20% serum or the indicated doses of EGF (Roche). For proliferation assays, MEFs were plated at a density of 3.75 Â 10 5 per 25-cm 2 flask and passaged every 3-4 days at the same density to determine the cumulative cell number. Senescence b-galactosidase staining kit protocol was used (Cell Signaling, Danvers, MA, USA). For rescue experiments, embryonic MEFs were seeded at a density of 4 Â 10 5 supplemented with growth factors HB-EGF (Sigma, St Louis, MO, USA) and EGF (Roche) or with antioxidants ascorbate (Vitamin C; Sigma), BHA (Sigma), and NAC (Calbiochem, Darmstadt, Germany) as indicated in the figure. For EGFR inhibitor experiments, fibroblasts were seeded at a density of 1 Â 10 5 per six-well overnight, inhibitors were added the next day, and cells were counted 2 days later. The following EGFR inhibitors were used: EGFR inhibitor (Calbiochem 324674), Erb-B2 inhibitor II (Calbiochem 324732), and EGFR/ErbB-2/ErbB-4 inhibitor (Calbiochem 324840).
The reporter constructs were transfected into Jun þ / þ , Jun
, and Jun
À/À
MEFs by using the Lipofectamine Plus Reagent (Life Technologies, Carlsbad, CA, USA). Each transfection was performed in triplicate in 24-well plates and the Renilla luciferase reporter pRL-SV40 (Promega, Madison, WI, USA) was cotransfected as an internal control. Promoter luciferase reporter constructs used in the study include p53 (p53-promo-luc) 20 and cyclin D1 (cD1-promo-luc). 24 Cells were harvested 24 h after transfection, or starved in 0.5% FCS overnight and restimulated for 8 h. Cell extracts were prepared and the Luciferase activity was measured according to the Dual-Luciferase Reporter Assay System (Promega). All Firefly luciferase reporter activities were normalized for transfection efficiency by determining the ratio between Firefly and Renilla luciferase activity. The mean ± S.D. is shown.
